DK1140027T3 - Doseringsformer indeholdende poröse partikler - Google Patents
Doseringsformer indeholdende poröse partiklerInfo
- Publication number
- DK1140027T3 DK1140027T3 DK99962459T DK99962459T DK1140027T3 DK 1140027 T3 DK1140027 T3 DK 1140027T3 DK 99962459 T DK99962459 T DK 99962459T DK 99962459 T DK99962459 T DK 99962459T DK 1140027 T3 DK1140027 T3 DK 1140027T3
- Authority
- DK
- Denmark
- Prior art keywords
- forms
- active agent
- pores
- dosage forms
- particles
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 3
- 239000002245 particle Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 abstract 3
- 239000011148 porous material Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002745 absorbent Effects 0.000 abstract 1
- 239000002250 absorbent Substances 0.000 abstract 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 abstract 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 abstract 1
- 235000019700 dicalcium phosphate Nutrition 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11375098P | 1998-12-23 | 1998-12-23 | |
| US11361598P | 1998-12-23 | 1998-12-23 | |
| US11355998P | 1998-12-23 | 1998-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140027T3 true DK1140027T3 (da) | 2006-02-27 |
Family
ID=27381339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99962459T DK1140027T3 (da) | 1998-12-23 | 1999-12-23 | Doseringsformer indeholdende poröse partikler |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1140027B1 (da) |
| JP (1) | JP2002533380A (da) |
| KR (1) | KR100618234B1 (da) |
| AT (1) | ATE306250T1 (da) |
| AU (1) | AU1881600A (da) |
| CA (1) | CA2355860C (da) |
| DE (1) | DE69927708T2 (da) |
| DK (1) | DK1140027T3 (da) |
| ES (1) | ES2251251T3 (da) |
| HK (1) | HK1040921B (da) |
| IL (2) | IL143846A0 (da) |
| WO (1) | WO2000038655A1 (da) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9808052D0 (en) | 1998-04-17 | 1998-06-17 | Secr Defence | Implants for administering substances and methods of producing implants |
| US6793934B1 (en) * | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
| DK1322158T3 (da) * | 2000-10-02 | 2012-11-19 | Usv Ltd | Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf |
| EP1578246B1 (en) * | 2001-07-12 | 2014-09-03 | Given Imaging Ltd. | Device for examining a body lumen |
| KR20050043765A (ko) * | 2001-11-06 | 2005-05-11 | 랜박시 래보러터리스 리미티드 | 방출 제어형 메트포르민 정제 |
| HUP0402451A3 (en) * | 2001-12-19 | 2008-04-28 | Alza Corp | Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
| ITMI20021392A1 (it) * | 2002-06-25 | 2003-12-29 | Nicox Sa | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
| CA2490412A1 (en) * | 2002-06-28 | 2004-01-08 | Alza Corporation | Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition |
| US20080070308A1 (en) * | 2004-06-28 | 2008-03-20 | Thomas Ruhland | Portous Article For Delivering Chemical Substances |
| CN1976751A (zh) * | 2004-06-28 | 2007-06-06 | H.隆德贝克有限公司 | 释放化学物质的多孔物品 |
| FR2873923B1 (fr) * | 2004-08-05 | 2007-01-12 | Gattefosse Holding Sa | Particule solide anhydre contenant une composition lipidique liquide et composition pharmaceutique contenant lesdites particules |
| GB0420016D0 (en) * | 2004-09-09 | 2004-10-13 | Leuven K U Res & Dev | Controlled release oral delivery system |
| EP1817021A1 (en) * | 2004-11-03 | 2007-08-15 | Equitech Corporation | Nsaid compositions exhibiting clinical superiority |
| CA2611724C (en) * | 2005-06-10 | 2014-07-29 | Pierre Fabre Medicament S.A. | Stabilized milnacipran formulation |
| DE602005007205D1 (de) * | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive Zusammensetzungen und Verfahren zur Herstellung |
| KR100669497B1 (ko) * | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법 |
| WO2007076699A1 (en) * | 2005-12-31 | 2007-07-12 | Tianjin Tasly Pharmaceutical Co. Ltd., China | Pharmaceutical composition containing chenopodium ambrosioides extract and its preparing process and application |
| US20090186081A1 (en) * | 2006-01-05 | 2009-07-23 | Lifecycle Pharma A/S | Disintegrating Loadable Tablets |
| GB0709541D0 (en) * | 2007-05-17 | 2007-06-27 | Jagotec Ag | Pharmaceutical excipient |
| EP2223702B1 (en) * | 2007-12-03 | 2019-05-08 | Tomita Pharmaceutical Co., Ltd. | Core particle for pharmaceutical preparation |
| US9150419B2 (en) * | 2008-05-10 | 2015-10-06 | Us Synthetic Corporation | Polycrystalline articles for reagent delivery |
| EP2135601A1 (en) * | 2008-06-20 | 2009-12-23 | Capsulution Nanoscience AG | Stabilization of amorphous drugs using sponge-like carrier matrices |
| JP5560701B2 (ja) * | 2008-12-26 | 2014-07-30 | ライオン株式会社 | ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法 |
| CN102413813B (zh) * | 2009-03-24 | 2014-11-12 | Adds制药有限责任公司 | 用于口服递送的稳定化的溶解性增强的制剂 |
| EP2427179A4 (en) | 2009-05-04 | 2013-09-11 | Psivida Inc | POROUS SILICON MEDICATION ELUTING PARTICLES |
| US8798388B2 (en) | 2009-12-03 | 2014-08-05 | Qualcomm Incorporated | Digital image combining to produce optical effects |
| EP2515759A4 (en) | 2009-12-23 | 2015-01-21 | Given Imaging Inc | METHOD OF ASSESSING CONSTIPATION USING INGREDIENT CAPSULE |
| US20110244031A1 (en) * | 2010-03-31 | 2011-10-06 | Lifecycle Pharma A/S | Porous tablets as carriers for liquid formulations |
| US20130143894A1 (en) * | 2010-06-07 | 2013-06-06 | vadel Pharma Inc. | Oral spray formulations ad methods for administration of sildenafil |
| CN103282020B (zh) | 2010-11-01 | 2016-10-26 | 普西维达公司 | 用于递送治疗剂的可生物侵蚀的硅基装置 |
| WO2012166949A1 (en) | 2011-05-31 | 2012-12-06 | Regents Of The University Of Minnesota | Silicate prodrugs and nanoparticles |
| CN104822368B (zh) * | 2011-12-05 | 2019-01-11 | 苏达公司 | 西地那非口腔喷雾制剂及其给药方法 |
| DK3677252T3 (da) | 2012-03-19 | 2023-10-02 | Cidara Therapeutics Inc | Doseringsregimer for echinocandin-klasse forbindelser |
| CA2873837C (en) | 2012-05-21 | 2021-01-19 | Capsugel Belgium Nv | Acid resistant banding solution for two piece hard capsules |
| CA2875818A1 (en) * | 2012-07-27 | 2014-01-30 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for bedwetting and method of use thereof |
| RU2695536C2 (ru) * | 2013-03-12 | 2019-07-23 | Айпоинт Фармасьютикалз Юэс, Инк. | Устройство для доставки лекарственных средств, содержащее частицы носителя на основе кремния |
| AU2014235051B2 (en) | 2013-03-15 | 2019-01-17 | Eyepoint Pharmaceuticals Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
| PL3137057T3 (pl) * | 2014-05-01 | 2021-04-06 | Sun Pharmaceutical Industries Ltd | Kompozycje ciekłe metforminy o przedłużonym uwalnianiu |
| AU2015294912A1 (en) | 2014-07-30 | 2017-02-16 | Sun Pharmaceutical Industries Limited | Dual-chamber pack |
| EP3137060B2 (en) | 2014-05-01 | 2023-12-20 | Sun Pharmaceutical Industries Ltd | Extended release suspension compositions |
| US20180104197A9 (en) | 2014-05-01 | 2018-04-19 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of metformin |
| US9962336B2 (en) | 2014-05-01 | 2018-05-08 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
| US10258583B2 (en) | 2014-05-01 | 2019-04-16 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of guanfacine |
| MA41124A (fr) * | 2014-12-05 | 2017-10-10 | Sun Pharmaceutical Ind Ltd | Compositions en suspension à libération prolongée à rétention gastrique |
| US10500201B2 (en) | 2014-12-23 | 2019-12-10 | Lucideon Limited | Porous particles |
| GB201502073D0 (en) | 2015-02-09 | 2015-03-25 | Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd | HDEG technology |
| US10238803B2 (en) | 2016-05-02 | 2019-03-26 | Sun Pharmaceutical Industries Limited | Drug delivery device for pharmaceutical compositions |
| US10369078B2 (en) | 2016-05-02 | 2019-08-06 | Sun Pharmaceutical Industries Limited | Dual-chamber pack for pharmaceutical compositions |
| EP3810092A4 (en) * | 2018-06-25 | 2022-04-20 | Titan Pharmaceuticals, Inc. | LOADED POROUS STRUCTURES FOR USE AS IMPLANTS |
| WO2020230089A1 (en) | 2019-05-14 | 2020-11-19 | Clexio Biosciences Ltd. | Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease |
| WO2022195476A1 (en) | 2021-03-15 | 2022-09-22 | Clexio Biosciences Ltd. | Gastroretentive devices for assessment of intragastric conditions |
| CN115924903B (zh) * | 2022-12-01 | 2024-08-20 | 复旦大学 | 一种二维单层有序介孔碳框架的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2155889B (en) * | 1984-03-21 | 1988-03-02 | Alza Corp | Dispenser-capsule |
| GB8413191D0 (en) * | 1984-05-23 | 1984-06-27 | Beecham Group Plc | Pharmaceutical composition |
| DK0448091T3 (da) * | 1990-03-23 | 1999-05-03 | Yoshitomi Pharmaceutical | Farmaceutisk præparat indeholdende et i ringe grad vandopløseligt medikament |
| JP2700141B2 (ja) * | 1993-09-17 | 1998-01-19 | 富士化学工業株式会社 | リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤 |
| US5800834A (en) * | 1996-06-10 | 1998-09-01 | Spireas; Spiridon | Liquisolid systems and methods of preparing same |
| ES2242273T3 (es) * | 1997-03-03 | 2005-11-01 | Sanofi-Aventis | Formulaciones farmaceuticas que contienen sustancias farmaceuticas deficientemente solubles. |
| US5955086A (en) * | 1998-06-18 | 1999-09-21 | Biotics Research Corporation | Oregano for the treatment of internal parasites and protozoa |
| US6376481B2 (en) * | 1998-09-02 | 2002-04-23 | Mcneil-Ppc, Inc. | Sterol esters in tableted solid dosage forms |
-
1999
- 1999-12-23 AT AT99962459T patent/ATE306250T1/de active
- 1999-12-23 AU AU18816/00A patent/AU1881600A/en not_active Abandoned
- 1999-12-23 WO PCT/GB1999/004426 patent/WO2000038655A1/en not_active Ceased
- 1999-12-23 EP EP99962459A patent/EP1140027B1/en not_active Expired - Lifetime
- 1999-12-23 DE DE69927708T patent/DE69927708T2/de not_active Expired - Lifetime
- 1999-12-23 DK DK99962459T patent/DK1140027T3/da active
- 1999-12-23 KR KR1020017008072A patent/KR100618234B1/ko not_active Expired - Fee Related
- 1999-12-23 IL IL14384699A patent/IL143846A0/xx active IP Right Grant
- 1999-12-23 ES ES99962459T patent/ES2251251T3/es not_active Expired - Lifetime
- 1999-12-23 CA CA2355860A patent/CA2355860C/en not_active Expired - Fee Related
- 1999-12-23 JP JP2000590609A patent/JP2002533380A/ja not_active Withdrawn
- 1999-12-23 HK HK02102704.1A patent/HK1040921B/en not_active IP Right Cessation
-
2001
- 2001-06-19 IL IL143846A patent/IL143846A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2355860A1 (en) | 2000-07-06 |
| ES2251251T3 (es) | 2006-04-16 |
| EP1140027B1 (en) | 2005-10-12 |
| DE69927708D1 (de) | 2006-02-23 |
| JP2002533380A (ja) | 2002-10-08 |
| IL143846A0 (en) | 2002-04-21 |
| ATE306250T1 (de) | 2005-10-15 |
| HK1040921A1 (en) | 2002-06-28 |
| KR20010093218A (ko) | 2001-10-27 |
| WO2000038655A1 (en) | 2000-07-06 |
| IL143846A (en) | 2007-03-08 |
| CA2355860C (en) | 2010-03-30 |
| EP1140027A1 (en) | 2001-10-10 |
| KR100618234B1 (ko) | 2006-09-01 |
| AU1881600A (en) | 2000-07-31 |
| DE69927708T2 (de) | 2006-07-06 |
| HK1040921B (en) | 2005-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1140027T3 (da) | Doseringsformer indeholdende poröse partikler | |
| MY132999A (en) | New formulation for inhalation | |
| HUP0500639A2 (hu) | Mosószeradalék, előállítása, alkalmazása és ilyet tartalmazó mosószerkészítmény | |
| AR015992A1 (es) | Composiciones secuestradoras de oxigeno, producto que lo contiene y metodo para secuestrar oxigeno que emplea dicha composicion | |
| NO20064395L (no) | Anvendelse av buprenorfin i fremstilling av et medikament | |
| WO2001048303A3 (en) | A wiper containing a controlled-release anti-microbial agent | |
| GR3033301T3 (en) | Medicament form for the delivery of active substances to wounds | |
| IS5110A (is) | Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur búdesóníð | |
| EP0494996A4 (en) | Erodible macroporous hydrogel particles and preparation thereof | |
| IS2243B (is) | Ný efnablanda til innöndunar sem er með lausþéttniflæði frá 0,28 til 0,38 g/ml, sem inniheldur formóteról | |
| HUP9802498A2 (hu) | Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására | |
| IL115869A0 (en) | Implantable device for the administration of active substances to plants and a process for the production thereof | |
| EP1080709A3 (en) | Absorbent article | |
| EE9900293A (et) | Uus inhaleeritav terbutaliinsulfaati sisaldav ravimvorm puistetihedusega 0,28 kuni 0,38 g/ml, selle valmistamise protsess ja kasutamine | |
| EP0384267A3 (en) | Therapeutic system for the sustained and controlled transdermal or transmucosal delivery of active agents | |
| HUP0003566A2 (hu) | Eljárás dózisforma előállítására, az előállított termék és alkalmazása | |
| IL124538A (en) | Transdermal delivery system for pharmaceutical compositions and a process for the preparation thereof | |
| JPH0726321Y2 (ja) | 電話機の除菌具 | |
| UA39677A (uk) | Спосіб одержання покритої оболонкою таблетки корглікону | |
| UA40451C2 (en) | Method for manufacture of encapsulated dosage form | |
| TH24493A (th) | การใช้ประโยชน์สารที่มีกลิ่นหอม และในการปรุงแต่ง | |
| JP2004315046A (ja) | 医薬製剤用固形脱臭脱水剤 |